151 related articles for article (PubMed ID: 1464370)
21. Receptor specificity of the fibroblast growth factor family.
Ornitz DM; Xu J; Colvin JS; McEwen DG; MacArthur CA; Coulier F; Gao G; Goldfarb M
J Biol Chem; 1996 Jun; 271(25):15292-7. PubMed ID: 8663044
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of a fibroblast growth factor (FGF) binding domain in the cysteine-rich FGF receptor.
Zhou Z; Zuber ME; Burrus LW; Olwin BB
J Biol Chem; 1997 Feb; 272(8):5167-74. PubMed ID: 9030584
[TBL] [Abstract][Full Text] [Related]
23. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.
Wang F; Kan M; Yan G; Xu J; McKeehan WL
J Biol Chem; 1995 Apr; 270(17):10231-5. PubMed ID: 7730327
[TBL] [Abstract][Full Text] [Related]
24. Ligand-specific structural domains in the fibroblast growth factor receptor.
Wang F; Kan M; Xu J; Yan G; McKeehan WL
J Biol Chem; 1995 Apr; 270(17):10222-30. PubMed ID: 7730326
[TBL] [Abstract][Full Text] [Related]
25. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III.
Avivi A; Yayon A; Givol D
FEBS Lett; 1993 Sep; 330(3):249-52. PubMed ID: 8375495
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair.
Fernig DG; Gallagher JT
Prog Growth Factor Res; 1994; 5(4):353-77. PubMed ID: 7780086
[TBL] [Abstract][Full Text] [Related]
27. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
Zhang X; Ibrahimi OA; Olsen SK; Umemori H; Mohammadi M; Ornitz DM
J Biol Chem; 2006 Jun; 281(23):15694-700. PubMed ID: 16597617
[TBL] [Abstract][Full Text] [Related]
28. A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.
Yayon A; Zimmer Y; Shen GH; Avivi A; Yarden Y; Givol D
EMBO J; 1992 May; 11(5):1885-90. PubMed ID: 1316275
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factors.
Ornitz DM; Itoh N
Genome Biol; 2001; 2(3):REVIEWS3005. PubMed ID: 11276432
[TBL] [Abstract][Full Text] [Related]
30. Substitution of putative half-cystine residues in heparin-binding fibroblast growth factor receptors. Loss of binding activity in both two and three loop isoforms.
Hou J; Kan M; Wang F; Xu JM; Nakahara M; McBride G; McKeehan K; McKeehan WL
J Biol Chem; 1992 Sep; 267(25):17804-8. PubMed ID: 1325450
[TBL] [Abstract][Full Text] [Related]
31. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
Yeh BK; Igarashi M; Eliseenkova AV; Plotnikov AN; Sher I; Ron D; Aaronson SA; Mohammadi M
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2266-71. PubMed ID: 12591959
[TBL] [Abstract][Full Text] [Related]
32. Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities.
Werner S; Duan DS; de Vries C; Peters KG; Johnson DE; Williams LT
Mol Cell Biol; 1992 Jan; 12(1):82-8. PubMed ID: 1309595
[TBL] [Abstract][Full Text] [Related]
33. Interactions of FGFs with target cells.
Ledoux D; Gannoun-Zaki L; Barritault D
Prog Growth Factor Res; 1992; 4(2):107-20. PubMed ID: 1299353
[TBL] [Abstract][Full Text] [Related]
34. Overlapping expression and redundant activation of mesenchymal fibroblast growth factor (FGF) receptors by alternatively spliced FGF-8 ligands.
Blunt AG; Lawshé A; Cunningham ML; Seto ML; Ornitz DM; MacArthur CA
J Biol Chem; 1997 Feb; 272(6):3733-8. PubMed ID: 9013630
[TBL] [Abstract][Full Text] [Related]
35. Structure-based mutational analyses in FGF7 identify new residues involved in specific interaction with FGFR2IIIb.
Sher I; Yeh BK; Mohammadi M; Adir N; Ron D
FEBS Lett; 2003 Sep; 552(2-3):150-4. PubMed ID: 14527678
[TBL] [Abstract][Full Text] [Related]
36. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain.
Johnson DE; Lu J; Chen H; Werner S; Williams LT
Mol Cell Biol; 1991 Sep; 11(9):4627-34. PubMed ID: 1652059
[TBL] [Abstract][Full Text] [Related]
37. Modes of FGF release in vivo and in vitro.
D'Amore PA
Cancer Metastasis Rev; 1990 Nov; 9(3):227-38. PubMed ID: 2292137
[TBL] [Abstract][Full Text] [Related]
38. Identification of a cysteine-rich receptor for fibroblast growth factors.
Burrus LW; Zuber ME; Lueddecke BA; Olwin BB
Mol Cell Biol; 1992 Dec; 12(12):5600-9. PubMed ID: 1448090
[TBL] [Abstract][Full Text] [Related]
39. A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity.
Dell KR; Williams LT
J Biol Chem; 1992 Oct; 267(29):21225-9. PubMed ID: 1400433
[TBL] [Abstract][Full Text] [Related]
40. Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding.
Hanneken A
FEBS Lett; 2001 Feb; 489(2-3):176-81. PubMed ID: 11165245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
